7U5 Stock Overview
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BIOTON S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.73 |
| 52 Week High | zł0.85 |
| 52 Week Low | zł0.64 |
| Beta | 0.15 |
| 1 Month Change | 2.23% |
| 3 Month Change | -3.55% |
| 1 Year Change | -10.49% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -9.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7U5 | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 3.1% | 5.5% | 1.2% |
| 1Y | -10.5% | -3.7% | 10.1% |
Return vs Industry: 7U5 underperformed the German Biotechs industry which returned -3.7% over the past year.
Return vs Market: 7U5 underperformed the German Market which returned 10.1% over the past year.
Price Volatility
| 7U5 volatility | |
|---|---|
| 7U5 Average Weekly Movement | 4.2% |
| Biotechs Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7U5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7U5's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 357 | Jeremy Launders | www.bioton.pl |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
| 7U5 fundamental statistics | |
|---|---|
| Market cap | €64.02m |
| Earnings (TTM) | -€1.36m |
| Revenue (TTM) | €41.64m |
1.5x
P/S Ratio-47.1x
P/E RatioIs 7U5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7U5 income statement (TTM) | |
|---|---|
| Revenue | zł177.60m |
| Cost of Revenue | zł114.72m |
| Gross Profit | zł62.88m |
| Other Expenses | zł68.68m |
| Earnings | -zł5.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.068 |
| Gross Margin | 35.40% |
| Net Profit Margin | -3.27% |
| Debt/Equity Ratio | 6.8% |
How did 7U5 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 02:35 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BIOTON S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vladimira Urbankova | Erste Group Bank AG |
| Przemyslaw Sawala-Uryasz | UniCredit Research |
| Ovidiu Fer | Wood & Company |